[1] Köhler G, Milstein C.Continuous culture of fused cells secreting antibody of predefined specificity[J].Nature, 1975, 256 (5517): 495-497.
[2] Demarest SJ, Glaser SM.Antibody therapeutics, antibody engineering, and the merits of protein stability[J].Curr Opin Drug Discov Devel, 2008, 11(5): 675-687.
[3] Schneider CK.Monoclonal antibodies—regulatory challenges[J].Curr Pharm Biotechnol, 2008, 9(6): 431-438.
[4] Boulianne GL, Hozumi N, Shulman MJ.Production of functional chimaeric mouse/human antibody[J].Nature, 1984, 312(5995): 643-646.
[5] Siddiqui MZ.Monoclonal antibodies as diagnostics: an appraisal[J].Indian J Pharm Sci, 2010, 72(1): 12-17.
[6] Nakano K, Ishiguro T, Konishi H, et al.Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization[J].Anticancer Drugs, 2010, 21(10): 907-916.
[7] 孙梦梅, 靳彦文, 李平, 等.新型抗uPAR人源化抗体的表达和活性检测[J].军事医学, 2011, 35(4): 258-261.
[8] 孙思凡, 张部昌, 靳彦文.治疗性单克隆抗体研究进展[J].生物技术通讯, 2009, 20(2): 258-262.
[9] Harding FA, Stickler MM, Razo J, et al.The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions[J].MAbs, 2010, 2(3): 256-265.
[10] Kashmiri SV, De Pascalis R, Gonzales NR, et al.SDR grafting—a new approach to antibody humanization[J].Methods, 2005, 36(1): 25-34.
[11] Sehlin D, Hedlund M, Lord A, et al.Heavy-chain complementarity-determining regions determine conformation selectivity of anti-αβ antibodies[J].Neurodegener Dis, 2011, 8(3): 117-123.
[12] Kim KS, Kim HJ, Han BW, et al.Construction of a humanized antibody to hepatitis B surface antigen by specificity-determining residues(SDR)-grafting and de-immunization[J].Biochem Biophys Res Commun, 2010, 396(2): 231-237.
[13] 杜春红, 宋志忠, 于国林.单克隆抗体大量生产技术及研究进展[J].国际检验医学杂志, 2010, 31(3): 248-249.
[14] Schirrmann T, Hust M.Construction of human antibody gene libraries and selection of antibodies by phage display[J].Methods Mol Biol, 2010, 651(2): 177-209.
[15] 夏红利, 谭晨, 陈德杰, 等.从scFv噬菌体库分离特异性的人源化抗D-dimer抗体[J].中华微生物学和免疫学杂志, 2011, 31(2): 168-172.
[16] 胡占东, 公倩, 朱铁虹, 等.人源Fab段噬菌体抗体库的构建及抗IL-4抗体的初步筛选[J].天津医药, 2011, 39(6): 493-495.
[17] Smith GP.Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface[J].Science, 1985, 228(4705): 1315-1317.
[18] Huse WD, Sastry L, Iverson SA, et al.Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda[J].Science, 1989, 246(4935): 1275-1281.
[19] Vitaliti A, Wittmer M, Steiner R, et al.Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular endothelial growth-factor[J].Cancer Res, 2000, 60(16): 4311-4314.
[20] 何小鹃, 李官成, 朱建高, 等.鼻咽癌人源抗独特型单链抗体的制备及筛选[J].癌症, 2004, 23(2): 124-129.
[21] 朱建高, 李官成, 李跃辉, 等.全人源化抗结肠癌单链抗体基因的克隆和表达[J].生物工程学报, 2001, 17(5): 526-530.
[22] Knappik A, Ge L, Honegger A, et al.Fully synthetic human combinatorial antibody libraries(HuCAL)based on modular consensus frameworks and CDRs randomized with trinucleotides[J].J Mol Biol, 2000, 296(1): 57-86.
[23] Lamla T, Erdmann VA.Searching sequence space for high-affinity binding peptides using ribosome display[J].J Mol Biol, 2003, 329(2): 381-388.
[24] Tomizuka K, Shinohara T, Yoshida H, et al.Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies[J].Proc Natl Acad Sci U S A, 2000, 97(2): 722-727.
[25] 潘阳, 王露楠.单克隆抗体人源化技术研究进展[J].国际检验医学杂志, 2011, 32(13): 1483-1484.
[26] Cortez-Retamozo V, Backmann N, Senter PD, et al.Efficient cancer therapy with a nanobody-based conjugate[J].Cancer Res, 2004, 64(8): 2853-2857.
[27] Nakajima T, Mitsunaga M, Bander NH, et al.Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen(PSMA)positive tumors using the quenched humanized J591 antibody-indocyanine green(ICG) conjugate[J].Bioconjug Chem, 2011, 22(8): 1700-1705.
[28] Osborne JR, Akhtar NH, Vallabhajosula S, et al.Prostate-specific membrane antigen-based imaging[J].Urol Oncol, 2013, 31(2): 144-154.